Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Evaluating Placental Derived Allografts and Standard of Care in the Treatment of Nonhealing Diabetic Foot Ulcers Using Matched Controls

NCT07086443 is registered in ClinicalTrials.gov with Sequence LifeScience, Inc. as lead sponsor.

NCT NCT07086443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Evaluating Placental Derived Allografts and Standard of Care in the Treatment of Nonhealing Diabetic Foot Ulcers Using Matched Controls
Lead sponsor
Sequence LifeScience, Inc.
Phase
Phase 4
Overall status
Recruiting
Start date
July 11, 2025
Completion date
July 31, 2027
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dfu, diabetic foot ulcer, diabetic foot ulcer (dfu), foot ulcer due to type 1 diabetes mellitus, foot ulcer due to type 2 diabetes mellitus, ulcer, ulcer foot